Evidence map›Paper›PMID 32384127›Full record

ArticlePLoS pathogens2020

Past and ongoing adaptation of human cytomegalovirus to its host.

Alessandra Mozzi, Matteo Biolatti, Rachele Cagliani, Diego Forni, Valentina Dell'Oste, Chiara Pontremoli, Chiara Vantaggiato, Uberto Pozzoli, Mario Clerici, Santo Landolfo and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Immune surveillance of cytomegalovirus in tissues.Cellular & molecular immunology · 2024
    Review
  8. Article
  9. Article
  10. Genomic and geographical structure of human cytomegalovirus.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  11. Article
  12. Human herpesvirus diversity is altered in HLA class I binding peptides.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Alessandra MozziScientific Institute, IRCCS E. MEDEA, Bioinformatics, Bosisio Parini, Italy.
Matteo BiolattiLaboratory of Pathogenesis of Viral Infections, Department of Public Health and Pediatric Sciences, University of Turin, Turin, Italy.ORCID 0000-0001-7675-0762
Rachele CaglianiScientific Institute, IRCCS E. MEDEA, Bioinformatics, Bosisio Parini, Italy.
Diego ForniScientific Institute, IRCCS E. MEDEA, Bioinformatics, Bosisio Parini, Italy.
Valentina Dell'OsteLaboratory of Pathogenesis of Viral Infections, Department of Public Health and Pediatric Sciences, University of Turin, Turin, Italy.
Chiara PontremoliScientific Institute, IRCCS E. MEDEA, Bioinformatics, Bosisio Parini, Italy.ORCID 0000-0002-3022-502X
Chiara VantaggiatoScientific Institute, IRCCS E. MEDEA, Laboratory of Molecular Biology, Bosisio Parini, Italy.ORCID 0000-0002-3910-6836
Uberto PozzoliScientific Institute, IRCCS E. MEDEA, Bioinformatics, Bosisio Parini, Italy.ORCID 0000-0003-0670-7106
Mario ClericiDepartment of Physiopathology and Transplantation, University of Milan, Milan, Italy.ORCID 0000-0001-5920-6191
Santo LandolfoLaboratory of Pathogenesis of Viral Infections, Department of Public Health and Pediatric Sciences, University of Turin, Turin, Italy.
Manuela SironiScientific Institute, IRCCS E. MEDEA, Bioinformatics, Bosisio Parini, Italy.ORCID 0000-0002-2267-5266
IRCCS Eugenio Medea · ITUniversity of Turin · ITUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cytomegaloviruses (order Herpesvirales) display remarkable species-specificity as a result of long-term co-evolution with their mammalian hosts. Human cytomegalovirus (HCMV) is exquisitely adapted to our species and displays high genetic diversity. We leveraged information on inter-species divergence of primate-infecting cytomegaloviruses and intra-species diversity of clinical isolates to provide a genome-wide picture of HCMV adaptation across different time-frames. During adaptation to the human host, core viral genes were commonly targeted by positive selection. Functional characterization of adaptive mutations in the primase gene (UL70) indicated that selection favored amino acid replacements that decrease viral replication in human fibroblasts, suggesting evolution towards viral temperance. HCMV intra-species diversity was largely governed by immune system-driven selective pressure, with several adaptive variants located in antigenic domains. A significant excess of positively selected sites was also detected in the signal peptides (SPs) of viral proteins, indicating that, although they are removed from mature proteins, SPs can contribute to viral adaptation. Functional characterization of one of these SPs indicated that adaptive variants modulate the timing of cleavage by the signal peptidase and the dynamics of glycoprotein intracellular trafficking. We thus used evolutionary information to generate experimentally-testable hypotheses on the functional effect of HCMV genetic diversity and we define modulators of viral phenotypes.

Indexed as

Adaptation, BiologicalAdaptation, PhysiologicalAnimalsBiological EvolutionCytomegalovirusCytomegalovirus InfectionsEvolution, MolecularGlycoproteinsHost Microbial InteractionsHumansPhylogenySpecies SpecificityViral ProteinsGlycoproteinsViral Proteins

Identifiers

PMID32384127
PMCPMC7239485
OpenAlexW3022383838

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.